The Zacks Consensus Estimate for second-quarter earnings is pegged at $1.36 per share, implying a decline of 31.3% from the year-ago reported number. Three analysts have revised their estimates upward ...

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.